Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InBios International is a leading developer and manufacturer of immunodiagnostic devices for infectious diseases. The company has FDA-cleared ELISA kits for Zika virus, dengue virus and West Nile virus; rapid test kits for Chagas and leishmaniasis; and received multiple FDA Emergency Use Authorizations (EUAs) during the COVID‑19 pandemic. It is also advancing new diagnostics such as a next-generation Lyme disease test as part of the LymeX Diagnostics Prize competition[1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InBios International.